NCT00438360View on ClinicalTrials.gov

Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

Cyclosporine A microemulsion

Oral soft gelatin capsules of Cyclosporine 10 mg, 25 mg, 50 mg or 100 mg administered twice a week for 24 weeks at the dosage of 5 mg/Kg/day in two daily administrations

DRUG

Placebo

Oral soft gelatin capsules of placebo matching cyclosporine administered twice a week for 24 weeks in two daily administrations

Trial Locations (1)

Unknown

Novartis Investigative Site, Bari

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY